DD120192A5 - - Google Patents

Info

Publication number
DD120192A5
DD120192A5 DD187639A DD18763975A DD120192A5 DD 120192 A5 DD120192 A5 DD 120192A5 DD 187639 A DD187639 A DD 187639A DD 18763975 A DD18763975 A DD 18763975A DD 120192 A5 DD120192 A5 DD 120192A5
Authority
DD
German Democratic Republic
Application number
DD187639A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD120192A5 publication Critical patent/DD120192A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
DD187639A 1974-08-05 1975-08-01 DD120192A5 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2438020A DE2438020A1 (de) 1974-08-05 1974-08-05 18-methyl-19-nor-20-keto-pregnane und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
DD120192A5 true DD120192A5 (cg-RX-API-DMAC10.html) 1976-06-05

Family

ID=5922668

Family Applications (1)

Application Number Title Priority Date Filing Date
DD187639A DD120192A5 (cg-RX-API-DMAC10.html) 1974-08-05 1975-08-01

Country Status (17)

Country Link
US (1) US4029777A (cg-RX-API-DMAC10.html)
JP (1) JPS5141347A (cg-RX-API-DMAC10.html)
AT (1) AT345998B (cg-RX-API-DMAC10.html)
BE (1) BE832124A (cg-RX-API-DMAC10.html)
CA (1) CA1037027A (cg-RX-API-DMAC10.html)
CH (1) CH611910A5 (cg-RX-API-DMAC10.html)
CS (2) CS175498B2 (cg-RX-API-DMAC10.html)
DD (1) DD120192A5 (cg-RX-API-DMAC10.html)
DE (1) DE2438020A1 (cg-RX-API-DMAC10.html)
DK (1) DK136369C (cg-RX-API-DMAC10.html)
ES (1) ES439720A1 (cg-RX-API-DMAC10.html)
FR (1) FR2281123A1 (cg-RX-API-DMAC10.html)
GB (1) GB1512258A (cg-RX-API-DMAC10.html)
HU (1) HU171684B (cg-RX-API-DMAC10.html)
IL (1) IL47770A (cg-RX-API-DMAC10.html)
NL (1) NL7509326A (cg-RX-API-DMAC10.html)
SE (1) SE404804B (cg-RX-API-DMAC10.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61144199A (ja) * 1984-12-18 1986-07-01 Pioneer Electronic Corp スピ−カ用紙製振動部材の製造方法
EP0382790A4 (en) * 1987-08-25 1991-03-27 Kelvin W. Gee Compositions and methods for alleviating stress, anxiety and seizure activity
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
US5175154A (en) * 1987-11-25 1992-12-29 Research Corporation Technologies, Inc. 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
BR112015026380A8 (pt) 2013-04-17 2019-12-31 Sage Therapeutics Inc esteróides de c21-n-pirazolil 19-nor c3,3-dissubstituídos e métodos de uso destes
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
CN117304245A (zh) 2013-04-17 2023-12-29 萨奇治疗股份有限公司 刺激神经活性的19-去甲类固醇及其使用方法
AU2014290400B2 (en) 2013-07-19 2019-12-05 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
EP3488852B1 (en) 2013-08-23 2020-10-28 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
CN117024502A (zh) 2014-10-16 2023-11-10 萨奇治疗股份有限公司 靶向cns障碍的组合物和方法
AU2015331597B2 (en) 2014-10-16 2020-04-30 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
EP3719029A1 (en) 2014-11-27 2020-10-07 Sage Therapeutics, Inc. Compositions for inducing sedation
DK3250210T3 (da) 2015-01-26 2021-03-08 Sage Therapeutics Inc Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser
WO2016134301A2 (en) 2015-02-20 2016-08-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
NZ749664A (en) 2016-07-11 2025-08-29 Sage Therapeutics Inc C17, c20, and c21 substituted neuroactive steroids and their methods of use
JP7065825B2 (ja) 2016-07-11 2022-05-12 セージ セラピューティクス, インコーポレイテッド C7、c12、およびc16置換神経刺激性ステロイドおよびそれらの使用方法
JP7382326B2 (ja) * 2017-12-22 2023-11-16 セージ セラピューティクス, インコーポレイテッド Cns障害の処置のための組成物および方法
AR119047A1 (es) 2019-05-31 2021-11-17 Sage Therapeutics Inc Esteroides neuroactivos como moduladores de gabaa y su uso en el tratamiento de trastornos del snc

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791196A (fr) * 1971-11-11 1973-05-10 Glaxo Lab Ltd Nouveaux steroides, leur procede de preparation et leurs applications
GB1409239A (en) * 1971-11-11 1975-10-08 Glaxo Lab Ltd Process for the preparation of 3alpha-hydroxy-5alpha-steroids

Also Published As

Publication number Publication date
DK344475A (da) 1976-02-06
NL7509326A (nl) 1976-02-09
IL47770A0 (en) 1975-10-15
CS175500B2 (cg-RX-API-DMAC10.html) 1977-05-31
GB1512258A (en) 1978-05-24
DK136369B (da) 1977-10-03
IL47770A (en) 1978-10-31
CH611910A5 (cg-RX-API-DMAC10.html) 1979-06-29
AT345998B (de) 1978-10-10
BE832124A (fr) 1976-02-05
CA1037027A (en) 1978-08-22
CS175498B2 (cg-RX-API-DMAC10.html) 1977-05-31
SE404804B (sv) 1978-10-30
ES439720A1 (es) 1977-03-01
JPS5141347A (en) 1976-04-07
FR2281123A1 (fr) 1976-03-05
ATA600475A (de) 1978-02-15
DE2438020A1 (de) 1976-02-26
HU171684B (hu) 1978-02-28
AU8351575A (en) 1977-02-03
US4029777A (en) 1977-06-14
SE7508777L (sv) 1976-02-06
DK136369C (da) 1978-02-27

Similar Documents

Publication Publication Date Title
CS175498B2 (cg-RX-API-DMAC10.html)
DK274375A (cg-RX-API-DMAC10.html)
AU7891375A (cg-RX-API-DMAC10.html)
AR199810A1 (cg-RX-API-DMAC10.html)
AU495028B2 (cg-RX-API-DMAC10.html)
DK134419C (cg-RX-API-DMAC10.html)
FR2257420B1 (cg-RX-API-DMAC10.html)
AU7237274A (cg-RX-API-DMAC10.html)
AU7470174A (cg-RX-API-DMAC10.html)
AU7478474A (cg-RX-API-DMAC10.html)
FI740154A0 (cg-RX-API-DMAC10.html)
AU480783A (cg-RX-API-DMAC10.html)
BG19616A1 (cg-RX-API-DMAC10.html)
AU480470A (cg-RX-API-DMAC10.html)
AU480208A (cg-RX-API-DMAC10.html)
AU480070A (cg-RX-API-DMAC10.html)
AU479969A (cg-RX-API-DMAC10.html)
AU479769A (cg-RX-API-DMAC10.html)
AU479634A (cg-RX-API-DMAC10.html)
BG19962A1 (cg-RX-API-DMAC10.html)
BG19720A1 (cg-RX-API-DMAC10.html)
BE837371A (cg-RX-API-DMAC10.html)
AU480879A (cg-RX-API-DMAC10.html)
BG19943A1 (cg-RX-API-DMAC10.html)
AU480902A (cg-RX-API-DMAC10.html)